Animal microbiome Diagnostics Market to Reach $6.4B as Pet Owners and Farmers Seek Gut Health Insights
[SAN FRANCISCO, USA – May 14th, 2025] – The animal microbiome diagnostics market is projected to grow at a 24% CAGR, reaching $6.4B by 2031, according to a new 350-page ClearView report.
Request Sample @ https://clearviewmarketinsights.com/report-details/animal-microbiome-diagnostics-market/
Key drivers:
Industry Shifts
- Regulatory Catalysts:
- EU bans feed-grade antibiotics (2024).
- China’s aquaculture microbiome funding ($200M).
- Clinical Proof:
- AnimalBiome’s Test: Reduces canine diarrhea by 65%.
- DSM’s Tool: Boosts milk yield 12% (Cornell study).
- Consumer Trends:
- 62% of pet owners prioritize gut health (Packaged Facts).
- "Microbiome-Certified" pet food sells at 2.5x premium.
Executive Quotes
- Holly Ganz, AnimalBiome CEO:
"Gut health is the new wellness frontier—for pets and profits." - Dr. Markus Wyss, DSM R&D Head:
"Our tools cut antibiotics without sacrificing yield."
Future Projections
- 2026: First fecal transplant kits for pets ($149 MSRP).
- 2030: 60% of livestock farms use microbiome testing.
For more insights, visit https://clearviewmarketinsights.com/
About ClearView Market Insights Analytics
ClearView Market Insights Analytics is a global leader in industrial technology research, offering actionable insights across more than 100 laser market segments.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369